May 23, 2024 11:17 GMT
Medtronic: FY24 Results
HEALTHCARE
Medtronic (MDT: A3 /A) 4Q24 Results
Medtronic has EUR 2.5bn due in 2025 and has not issued since 2023. The company took on significant debt in 2015 but had reduced this to a stable total of $25bn since 2019. With a weighted average maturity of 10.6yrs the company’s policy is to keep rolling the debt over at reasonably long tenors. The rating has been stable at A3/A for 7yrs+.
Solid results:
- Revenue $8.6b slightly ahead of consensus
- Guiding for 4-5% organic revenue growth 2025
- FY24 FCF $5.2bn increased 14% YoY
- Emphasis on the $5.5b returned to shareholders. Clearly debt is not the priority here as it has been stable for years.
Watch for issuance in coming days.
Keep reading...Show less
116 words